Alembic Pharmaceuticals has clinched tentative approval from the US Food & Drug Administration (USFDA) for its Bosutinib Tablets, 400?mg — a major generic cancer drug move that expands its foothold in the lucrative US oncology market...
Metropolis Healthcare launches Centre of Genomics, offering advanced sequencing, precision medicine, AI-driven insights, and clinically integrated genomic diagnostics in India.
Aurobindo Pharma pegfilgrastim biosimilar has received a major boost after the company’s wholly owned biosimilars subsidiary, CuraTeQ Biologics, secured regulatory clearance in Canada. Canadian health regulator, Health Canada has issued a Notice...
Gland Pharma USFDA approval marks a fresh milestone for the Hyderabad-based drugmaker, as it has received clearance from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride Ophthalmic S.
GSK has obtained a new prefilled syringe variant of Shingrix, which is an update to one of the most popular brands of shingles vaccines globally. The ruling paves the way to an improved presentation that will save time on preparation and...
Eli Lilly buys Ventyx as it builds its infiltration in inflammation-related diseases. The Indianapolis-based pharma giant reported today that it has initiated into a final deal to acquire Ventyx Biosciences. Ventyx Biosciences is a San Diego...
Sun Pharmaceutical Industries has secured a major win after the Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal granted Sun Pharma CESTAT relief by setting aside a Rs 39 crore excise duty demand raised by tax authorities...
Hindustan Laboratories has filed IPO papers with SEBI, preparing for its market debut and signaling a strategic move to expand operations in India’s fast?growing generic drug market. The submission is made at a time when there is still a high...
The World Health Organization (WHO) has prequalified two rapid antigen test diagnostics (Ag-RDTs) for SARS-CoV-2 infections. This is historic, as Ag-RDTs are now prequalified for use for the first time.
Practo, a digital healthcare platform, plans to hit $1 billion in yearly gross merchandise value (GMV) by June 2026.